Change Healthcare vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 60)
Change Healthcare logo

Change Healthcare

ChallengerHealthcare

Revenue Cycle

Healthcare clearinghouse processing 15B+ annual claims acquired by Optum; 2024 ransomware attack caused $1B+ provider disruption and sparked nationwide healthcare cybersecurity overhaul.

AI VisibilityBeta
Overall Score
B60
Category Rank
#123 of 596
AI Consensus
82%
Trend
stable
Per Platform
ChatGPT
56
Perplexity
55
Gemini
62

About

Change Healthcare (now part of Optum) is a healthcare technology company providing claims processing, payment management, network intelligence, and clinical decision support tools to the US healthcare ecosystem — connecting payers, providers, pharmacies, and patients through data and technology infrastructure. Change Healthcare was acquired by UnitedHealth Group's Optum subsidiary in October 2022 following a lengthy regulatory review that included a DOJ lawsuit to block the acquisition on antitrust grounds.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
up
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

60
Overall Score
90
#123
Category Rank
#2
82
AI Consensus
83
stable
Trend
up
56
ChatGPT
92
55
Perplexity
93
62
Gemini
89
60
Claude
96
60
Grok
95

Key Details

Category
Revenue Cycle
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Change Healthcare
Revenue Cycle

Integrations

Only Moderna
Moderna is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.